QR Code

S103: EFFICACY AND SAFETY OF ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR-T CELL THERAPY WITH FRACTIONATED INITIAL THERAPY AND BOOSTER DOSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

I tiakina i:
Ngā kaituhi matua: C. Fernandez De Larrea, V. González-Calle, A. Oliver-Caldés, V. Cabañas, P. Rodríguez-Otero, M. Español-Rego, J. L. Reguera, L. López-Corral, B. Martin-Antonio, B. Paiva, S. Inogés, L. Rosiñol, A. López-Díaz de Cerio, N. Tovar, M. López-Parra, L. G. Rodríguez-Lobato, A. Sánchez-Salinas, S. Varea, V. Ortiz-Maldonado, J. A. Pérez Simón, F. Prósper, M. Juan, J. M. Moraleda, M. V. Mateos, M. Pascal, A. Urbano-Ispizua
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wiley 2022-06-01
Rangatū:HemaSphere
Urunga tuihono:http://journals.lww.com/10.1097/01.HS9.0000843308.71619.a0
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite